Genetic prediction of coronary heart disease: Lessons from Canada

References

• Healthy people 2000: National health promotion and disease prevention objectives. Hyattsville, MD 1990, US Department of Health and Human Services publication (PHS) 91–50212
   Google Scholar
• Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998; 140: 199–270
   PubMed Web of Science ®Google Scholar
• Cheng S, Pallaud C, Grow M A, Scharf S J, Erlich H A, Klitz W, Pullinger C R, Malloy M J, Kane J P, Siest G, Visvikis S. A multilocus genotyping assay for cardiovascular disease. Clin Chem Lab Med 1998; 36: 561–6
   PubMedGoogle Scholar
• Report of a WHO consultation on familial hyper-cholesterolemia. Paris 1997, WHO/FGN/FH/WG/98.7
   Google Scholar
• Marenberg M E, Risch N, Berman L F, Floderus B, deFaire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1041–1046
   PubMed Web of Science ®Google Scholar
• Strong J P. Atherosclerotic lesions: natural history, risk factors and topography. Arch Path Lab Med 1992; 116: 1268–1275
   PubMed Web of Science ®Google Scholar
• Fuster V, Badimon L, Badimon J J, Chesebro J H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242–354
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 1993; 362: 801–809
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115–126
   PubMed Web of Science ®Google Scholar
• Sing C F, Haviland M B, Templeton A R, Reilly S L. Alternative genetic strategies for predicting risk of atherosclerosis. Atherosclerosis X Elsevier Science BV, F P Woodford, J Davignon, A D Sniderman, 1995; 638–644
   Google Scholar
• Hegele R A. Candidate genes, small effects, and the prediction of atherosclerosis. Crit Rev Clin Lab Sci 1997; 34: 343–67
   PubMed Web of Science ®Google Scholar
• Hegele R A. Small genetic effects in complex diseases: a review of regulatory sequence variants in dyslipoproteinemia and atherosclerosis. Clin Bio-chem 1997; 30: 183–8
   Google Scholar
• Hegele R A. The genetic basis of atherosclerosis. Int J Clin Lab Res 1997; 27: 2–13
   PubMedGoogle Scholar
• Lander E S, Schork N. Genetic dissection of complex traits. Science 1994; 265: 2037–2048
   PubMed Web of Science ®Google Scholar
• Goldstein J L, Brown M S. The clinical investigator: bewitched, bothered, and bewildered–but still beloved. J Clin Invest 1997; 99: 2803–2812
   PubMed Web of Science ®Google Scholar
• Wilson P W, Schaefer E J, Larson M G, Ordovas J M. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 1996; 16: 1250–5
   PubMed Web of Science ®Google Scholar
• Siest G, Pillot T, Regis-Bailly A, Leininger-Muller B, Steinmetz J, Galteau M M, Visvikis S. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995; 41: 1068–86
   PubMed Web of Science ®Google Scholar
• Butler R, Morris A D, Struthers A D. Angiotensin-converting enzyme gene polymorphism and cardiovascular disease. Clin Sci (Colch) 1997; 93: 391–400
   Google Scholar
• O'Dell S D, Humphries S E, Day I N. Rapid methods for population-scale analysis for gene polymorphisms: the ACE gene as an example. Br Heart J 1995; 73: 368–71
   PubMedGoogle Scholar
• Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubrier F. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 1996; 58: 1268–78
   PubMed Web of Science ®Google Scholar
• Scanu A M, Fless G M. Lipoprotein(a): heterogeneity and biological relevance. J Clin Invest 1990; 85: 1709–1715
   PubMed Web of Science ®Google Scholar
• Hegele R A, Brunt J H, Connelly P W. Multiple genetic determinants of variation of plasma lipoproteins in Alberta Hutterites. Arterioscler Thromb Vasc Biol 1995; 15: 861–871
   PubMed Web of Science ®Google Scholar
• Hegele R A, Brunt J H, Connelly P W. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994; 90: 2207–2212
   PubMed Web of Science ®Google Scholar
• Hegele R A, Brunt J H, Connelly P W. Genetic variation on chromosome 1 associated with variation in body fat distribution in men. Circulation 1995; 92: 1089–1093
   PubMed Web of Science ®Google Scholar
• Hegele R A, Harris S B, Hanley A J, Sadikian S, Connelly P W, Zinman B. Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab 1996; 81: 4334–4337
   PubMedGoogle Scholar
• Hegele R A, Connelly P W, Scherer S W, Hanley A J, Harris S B, Tsui L C, Zinman B. Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 3373–3377
   PubMed Web of Science ®Google Scholar
• Hegele R A, Connelly P W, Scherer S W, Hanley A J, Harris S B, Tsui L C, Zinman B. Paraoxonase-2 G148 variant in an aboriginal Canadian girl with non-insulin-dependent diabetes. Lancet 1997; 350: 785
   PubMedGoogle Scholar
• Hegele R A, Harris S B, Zinman B. Hemochromatosis and diabetes mellitus. Ann Intern Med 1998; 129: 587
   PubMedGoogle Scholar
• Hegele R A, Harris S B, Hanley A J, Azouz H, Connelly P W, Zinman B. Absence of association between genetic variation of the beta 3-adrenergic receptor and metabolic phenotypes in Oji-Cree. Diabetes Care 1998; 21: 851–854
   PubMedGoogle Scholar
• Hegele R A, Harris S B, Zinman B, Wang J, Cao H, Hanley A J, Tsui L C, Scherer S W. Variation in the AU(AT)-rich element within the 3′-untranslated region of PPP1R3 is associated with variation in plasma glucose in aboriginal Canadians. J Clin Endocrinol Metab 1998; 83: 3980–3983
   PubMedGoogle Scholar
• Hegele R A, Zinman B, Hanley A J, Harris S, Connelly P W. A common mtDNA polymorphism associated with variation in plasma triglyceride concentration. Am J Hum Genet 1997; 60: 1552–1555
   PubMedGoogle Scholar
• Hegele R A, Connelly P W, Hanley A J, Sun F, Harris S B, Zinman B. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. Arterioscler Thromb Vasc Biol 1997; 17: 1060–1066
   PubMed Web of Science ®Google Scholar
• Hegele R A, Connelly P W, Hanley A J, Sun F, Harris S B, Zinman B. Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins. Arterioscler Thromb Vasc Biol 1997; 17: 2753–2758
   PubMed Web of Science ®Google Scholar
• Hegele R A, Harris S B, Connelly P W, Hanley A J, Tsui L C, Zinman B, Scherer S W. Genetic variation in paraoxonase-2 is associated with variation in plasma lipoproteins in Canadian Oji-Cree. Clin Genet 1998; 54: 394–399
   PubMedGoogle Scholar
• Hegele R A, Harris S B, Hanley A J, Sun F, Connelly P W, Zinman B. Angiotensinogen gene variation associated with variation in blood pressure in aboriginal Canadians. Hypertension 1997; 29: 1073–1077
   PubMed Web of Science ®Google Scholar
• Hegele R A, Harris S B, Hanley A J, Sun F, Connelly P W, Zinman B. -6A promoter variant of angiotensinogen and blood pressure variation in Canadian Oji-Cree. J Hum Genet 1998; 43: 37–41
   PubMedGoogle Scholar
• Hegele R A, Harris S B, Hanley A J, Cao H, Zinman B. G protein beta3 subunit gene variant and blood pressure variation in Canadian Oji-Cree. Hypertension 1998; 32: 688–692
   PubMed Web of Science ®Google Scholar
• Hegele R A, Harris S B, Cao H, Hanley A J, Zinman B. Factor V Leiden (F5 Q506) and vascular disease in Canadian Oji-Cree. Diabetes Care 1998; 21: 1203
   PubMedGoogle Scholar
• Hegele R A, Wolever T M, Hanley A J, Harris S B, Zinman B. Methylenetetrahydrofolate reductase gene, dietary folate, NIDDM, and atherosclerosis in Canadian Oji-Cree. Diabetes Care 1998; 21: 322–323
   PubMedGoogle Scholar
• Hegele R A, Harris S B, Zinman B, Hanley A JG, Connelly P W. Increased plasma apolipoprotein B-containing lipoproteins associated with increased urinary albumin within the microalbuminuria range in type 2 diabetes. Clin Biochem 1999, in press
   Google Scholar
• Hegele R A, Harris S B, Hanley A JG, Zinman B. Association between AGT T235 variant and microalbuminuria in Canadian Oji-Cree with type 2 diabetes mellitus. Clin Biochem 1999, in press
   Google Scholar
• Hegele R A, Sun F, Harris S B, Anderson C, Hanley A JG, Zinman B. Genome-wide scanning for type 2 diabetes susceptibility in Canadian Oji-Cree using 190 microsatellite markers. J Hum Genet 1999; 44: 10–14
   PubMedGoogle Scholar
• Hegele R A, Cao H, Harris S B, Hanley A JG, Zinman B. HNF-1a G319S: a private mutation in Oji-Cree associated with type 2 diabetes. Diabetes Care 1999, in press
   Google Scholar
• Hegele R A, Cao H, Harris S B, Hanley A J, Zinman B. The hepatic nuclear factor-1 G319S variant is associated with early onset type 2 diabetes in Canadian Oji-Cree. J Clin Endo Metab 1999, in press
   PubMedGoogle Scholar
• Assmann G, Schulte H, von Eckardstein A. Hyper-triglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996; 77: 1179–84
   PubMed Web of Science ®Google Scholar
• Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study. Lancet 1994; 344: 1383–1389
   PubMedGoogle Scholar
• Williams R R, Hasstedt S J, Wilson D E, Ash K O, Yanowitz F F, Reiber G E, Kuida H. Evidence that med with familial hypercholesterolemia can avoid early death. An analysis of 77 gene carriers in four Utah pedigrees. JAMA 1986; 255: 219–224
   PubMedGoogle Scholar
• Hegele R A, Emi M, Wu L L, Hopkins P N, Williams R R, Lalouel J M. Clinical application of deoxyribonucleic acid markers in a Utah family with hypercholesterolemia. Am J Cardiol 1989; 63: 109–112
   PubMedGoogle Scholar
• Breslow J L. Familial disorders of high density lipoprotein metabolism. The Metabolic Basis of Inherited Diseases, C R Scriver, A L Beardet, W S Sly, D Valle. McGraw Hill Inc, New York 1989; 1251–66
   Google Scholar
• Assmann G, Schmitz G, Brewer H B, Jr. Familial high density lipoprotein deficiency: Tangier disease. The Metabolic Basis of Inherited Diseases, C R Scriver, A L Beaudet, W S Sly, D Valle. McGraw Hill Inc, New York 1989; 1267–82
   Google Scholar
• Funke H, Assmann G. The lowdown on lipoprotein lipase. Nat Genet 1995; 10: 6–7
   PubMedGoogle Scholar
• Ng D S, Leiter L A, Vezina C, Connelly P W, Hegele R A. Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with anal-phalipoproteinemia. J Clin Invest 1994; 93: 223–9
   PubMed Web of Science ®Google Scholar
• Anderson K M, Wilson P W, Odell P M, Kannel W B. An updated coronary risk profile. Circulation 1991; 83: 866–74
   PubMedGoogle Scholar
• Young T K, Moffatt M E, O'Neil J D. Cardiovascular diseases in a Canadian Arctic population. Am J Public Health 1993; 83: 881–887
   PubMed Web of Science ®Google Scholar
• Young T K. Chronic diseases among Canadian Indians: towards an epidemiology of culture change. Arctic Med Res 1988; 47: 434–441
   PubMedGoogle Scholar
• Moffatt M EK, Young T K, O'Neil J D, et al. The Keewatin Health Assessment Study. Arctic Med Res 1993; 52: 18–21
   PubMedGoogle Scholar
• Young T K, Nikitin Y P, Shubinov E V, Astakhova T I, Moffatt M EK, O'Neil J D. Plasma lipids in two indigenous arctic populations with low risk for cardiovascular diseases. Am J Hum Biol 1995; 7: 223–236
   PubMed Web of Science ®Google Scholar
• Hegele R A, Young T K, Connelly P W. Are Canadian Inuit at increased genetic risk for coronary heart disease?. J Mol Med 1997; 75: 364–370
   PubMed Web of Science ®Google Scholar
• Hegele R A, Tully C, Young T K, Connelly P W. V677 mutation of methylenetetra-hydrofolate reductase and cardiovascular disease in Canadian Inuit. Lancet 1997; 349: 1221–1222
   PubMed Web of Science ®Google Scholar
• Price D R, Ridker P M. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Int Med 1997; 127: 895–903
   PubMed Web of Science ®Google Scholar
• Guerra R, Wang J, Grundy S M, Cohen J C. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 1997; 94: 4532–4537
   PubMed Web of Science ®Google Scholar
• Xia J, Scherer S W, Cohen P TW, Majer M, Norman R A, Knowler W C, Bogardus C, Prochazka M. A common variant in PPPIR3 contributes to insulin resistance and type-2 diabetes. Diabetes 1998; 47: 1519–1524
   PubMed Web of Science ®Google Scholar
• Merryweather-Clarke A T, Pointon J J, Shearman J D, Robson K JH. Global prevalence of putative haemo-chromatosis mutations. J Med Genet 1997; 34: 275–278
   PubMed Web of Science ®Google Scholar
• Li W W, Dammerman M M, Smith J D, Metzger S, Breslow J L, Leff T. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J Clin Invest 1995; 96: 2601–2605
   PubMed Web of Science ®Google Scholar
• Young T K. Obesity, central fat patterning and their metabolic correlates among the inuit of the central arctic. Hum Biol 1996; 68: 245–263
   PubMed Web of Science ®Google Scholar
• Shah B, Hux J, Zinman B. Increasing incidence of ischemic heart disease among aboriginals in Northern Ontario. Can J Diab Care 1998; 22: A8
   Google Scholar
• Young T K, Szathmary E J, Evers S, Wheatley B. Geographical distribution of diabetes among the native population of Canada: a national survey. Soc Sci Med 1990; 129–139
   PubMedGoogle Scholar
• Harris S B, Gittelsohn J, Hanley A JG, Barnie A, Wolever T MS, Gao J, Logan A, Zinman B. The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 1997; 20: 185–197
   PubMed Web of Science ®Google Scholar
• Neel J V. The genetics of diabetes mellitus. Early Diabetes, R Camerini-Davalos, H S Cole. Academic Press, Inc., Orlando, FLA 1970; 3–10
   Google Scholar